Πλοήγηση ανά Συγγραφέα "Efstathiadou, Z."
-
Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women
Efstathiadou, Z.; Koukoulis, G.; Stakias, N.; Challa, A.; Tsatsoulis, A. (2004)Objectives: A number of studies have shown a positive relation between ApoE gene and osteoporosis or fracture risk but this finding has not been uniform in all populations studied. The aim of the present study was to ... -
Correlation of estrogen receptor beta gene polymorphisms with spinal bone mineral density in peri- and post-menopausal Greek women
Efstathiadou, Z.; Koukoulis, G.; Stakias, N.; Challa, A.; Zintzaras, E.; Tsatsoulis, A. (2006)Estrogens play a significant role in bone physiology. Their action is mainly exerted through their receptors. Estrogen receptor alpha (ER alpha) plays a major role in bone homeostasis and there is evidence suggesting that ... -
Effect of Exogenous Intermittent Recombinant Human PTH 1-34 Administration and Chronic Endogenous Parathyroid Hormone Excess on Glucose Homeostasis and Insulin Sensitivity
Anastasilakis, A. D.; Efstathiadou, Z.; Plevraki, E.; Koukoulis, G. N.; Slavakis, A.; Kita, M.; Avramidis, A. (2008)We aimed to evaluate the effects of exogenous intermittent teriparatide (rhPTH 1-34) administration versus the chronic exposure to excess endogenous parathyroid hormone (PTH), as in pHPT, on glucose homeostasis. Two patient ... -
Endogenous intact PTH is suppressed during teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis
Anastasilakis, A. D.; Polyzos, S. A.; Goulis, D. G.; Slavakis, A.; Efstathiadou, Z.; Kita, M.; Koukoulis, G.; Avramidis, A. (2008)Introduction: Teriparatide (recombinant human PTH 1-34/TPTD) is an osteoanabolic agent available for osteoporosis treatment. The aim of this prospective trial was to evaluate the acute and chronic effects of TPTD in ... -
Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial
Anastasilakis, A. D.; Goulis, D. G.; Polyzos, S. A.; Gerou, S.; Koukoulis, G. N.; Efstathiadou, Z.; Kita, M.; Avramidis, A. (2008)Aims: We aimed to compare the effect of risedronate (RIS) and teriparatide (TPTD) (recombinant human parathyroid hormone 1-34) on bone turnover markers in women with postmenopausal osteoporosis. Methods: Forty-four Caucasian ...